EID Parry, Claris Lifesciences, GAIL
India Equity Analysis, Reports, Recommendations, Stock Tips and more!
Search Now
Recommendations
Showing posts with label Claris Lifesciences. Show all posts
Showing posts with label Claris Lifesciences. Show all posts
Thursday, June 30, 2011
Wednesday, November 24, 2010
Claris Lifesciences IPO Analysis
The Ahmedabad-based Claris Lifesciences, promoted by Arjun S. Handa and Sarjan Financial Private Limited, is one of the largest Indian sterile injectables pharmaceutical companies with presence in 76 countries worldwide. It offers 128 products across multiple markets and therapeutic areas. All of its products are off-patent products, which range across various therapeutic segments, including anesthesia, critical care, anti-infectives, renal care, infusion therapy, enteral nutrition, parental nutrition and oncology. It offers injectables in various delivery systems, such as glass and plastic bottles, vials, ampoules, pre-filled syringes and non-PVC and PVC bags. Its customer base primarily includes government and private hospitals, aid agencies and nursing homes.
Subscribe to:
Posts (Atom)